IDERA PHARMACEUTICALS INC's ticker is IDRA and the CUSIP is 45168K306. A total of 92 filers reported holding IDERA PHARMACEUTICALS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $179,000 | +426.5% | 135,073 | +640.1% | 0.00% | – |
| Q1 2018 | $34,000 | -64.6% | 18,250 | -59.9% | 0.00% | – |
| Q4 2017 | $96,000 | -4.0% | 45,489 | +1.0% | 0.00% | – |
| Q3 2017 | $100,000 | +117.4% | 45,039 | +68.7% | 0.00% | – |
| Q2 2017 | $46,000 | -58.2% | 26,700 | -40.0% | 0.00% | – |
| Q1 2017 | $110,000 | -1.8% | 44,476 | -40.0% | 0.00% | – |
| Q4 2016 | $112,000 | +93.1% | 74,134 | +226.6% | 0.00% | – |
| Q3 2016 | $58,000 | +70.6% | 22,700 | +2.3% | 0.00% | – |
| Q2 2016 | $34,000 | -22.7% | 22,200 | 0.0% | 0.00% | – |
| Q1 2016 | $44,000 | -29.0% | 22,200 | +9.9% | 0.00% | – |
| Q4 2015 | $62,000 | -60.3% | 20,200 | -56.5% | 0.00% | – |
| Q3 2015 | $156,000 | +122.9% | 46,387 | +144.1% | 0.00% | – |
| Q2 2015 | $70,000 | +169.2% | 19,000 | +167.6% | 0.00% | – |
| Q1 2015 | $26,000 | -61.2% | 7,100 | -53.8% | 0.00% | – |
| Q4 2014 | $67,000 | – | 15,375 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|